Figure 2.
Cumulative incidence plot of the composite primary outcome (MI and stroke) in metastatic prostate cancer patients treated with ADT and abiraterone or enzalutamide.
ADT, androgen deprivation therapy; MI, myocardial infarction.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.